Axel Cangas/LinkedIn
Jul 19, 2026, 16:58
Axel Cangas: Exploring the Future of Hemophilia Care at ISTH 2026
Axel Cangas, Hematology and Immunology Unit Head at Roche México, shared a post on LinkedIn:
”Thrilled to be at International Society on Thrombosis and Haemostasis (ISTH) 2026 engaging with global experts on the incredible scientific advancements redefining haemophilia care.
It has been inspiring to see Roche’s deep, long-term commitment to this community.
We remain dedicated to standing alongside patients, families, and healthcare professionals for generations to come.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring